 |
|||
 |
|
CAT (AD/NAD/DA) - ELISA |
|
|
|||
|
|||
Catalog-No. |
EA603/288 Enzyme immunoassay for the quantitative determination of Adrenaline, Noradrenaline and Dopamine in Plasma and Urin
|
||
|
|||
|
|||
Format |
Sample voluime 15 microlitre urine, 300 microlitre plasma. Common extraction of urine and plasma in 48-well macrotiter plate. Acylation in liquid phase. 7 standards, 2 controls, ready for use. Common reagents for parallel testing. |
||
|
|||
|
|||
Procedure |
Extraction and Acylation 2,5 h and ELISA 15-20 h overnight |
||
|
|||
|
|||
Clinical Fields |
Endocrinology, Oncology, Psychiatry, Mental Health |
||
|
|||
|
|||
Diseases |
Pheochromocytoma, neuroblastoma, ganglioneuroma, degenerative cardiac diseases, hyper- and hypotension, schizophrenia, manic-depressive psychosis, stress, burn-out syndrome |
||
|
|||
|
|||
Normal Value |
Adrenaline < 20 µg//day for Urine; < 100 pg/ml for Plasma Noradrenaline 90 µg//day for Urine; < 600 pg/ml for Plasma Dopamine <600 µg//day for Urine; < 100 pg/ml for Plasma |
||
|
|||
|
|||
Specificity |
see data in the instruction for use |
||
|
|||
|
|||
Sensitivity |
Adrenaline 0.16 ng/ml for Urine; 8 pg/ml for Plasma Noradrenaline 0.85 ng/ml for Urine; 43 pg/ml for Plasma Dopamine 0.46 ng/ml for Urine; 23 pg/ml for Plasma |
||
|
|||
|
|||
Characteristics |
3x48 duplicate determinations or 3x96 single determ. All three analytes in one kit Wide standard range, convenient measurement of pathological samples without predilution No known interference by medical drugs High correlation with HPLC |
||
|
|||
